Steward Partners Investment Advisory’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Steward Partners Investment Advisory’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-530	Closed	-$28K	–	2413
2017 Q4	$28K	Sell	530 -29	-5%	-$1.59K	﹤0.01%	1014
2017 Q3	$31K	Buy	559 +125	+29%	+$7.32K	﹤0.01%	823
2017 Q2	$26K	Buy	434 +171	+65%	+$9.74K	﹤0.01%	800
2017 Q1	$14K	Buy	+263	New	+$13K	﹤0.01%	861

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Steward Partners Investment Advisory's BIVV Position: Q1 2018 in Review

Steward Partners Investment Advisory sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 530 shares — an estimated $28K sold.

Steward Partners Investment Advisory first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $31K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Steward Partners Investment Advisory reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Steward Partners Investment Advisory sold 530 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $28K.
Steward Partners Investment Advisory first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Steward Partners Investment Advisory's Bioverativ Inc. Common Stock position peaked at $31K in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2018, filed 20 Apr 2018.